[1] Joel M Palefsky, MD.人乳头瘤病毒感染的流行病学及其与疾病的关联. UpToDate 2021.
[2] Jason D Wright, MD.宫颈上皮内瘤变：专业术语、发病率、发病机制和预防.UpToDate 2021.
[3] Katki HA, Schiffman M, Castle PE, et al. Five-year risks of CIN 3+ and cervical cancer among women who test Pap-negative but are HPV-positive. J Low Genit Tract Dis 2013; 17:S56.
[4] Kjær SK, Frederiksen K, Munk C, Iftner T. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst 2010; 102:1478.
[5] Katki HA, Schiffman M, Castle PE, et al. Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines. J Low Genit Tract Dis 2013; 17:S28.
[6] Katki HA, Schiffman M, Castle PE, et al. Five-year risks of CIN 3+ and cervical cancer among women who test Pap-negative but are HPV-positive. J Low Genit Tract Dis 2013; 17:S56.
[7] Michael Frumovitz, MD.浸润性宫颈癌的流行病学、危险因素、临床表现和诊断.UpToDate 2021.
[8] Christopher P Crum, MD.宫颈和阴道细胞学：解读检查结果(巴氏涂片报告).UpToDate 2021.
[9] Cox JT, Castle PE, Behrens CM, et al. Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV study. Am J Obstet Gynecol 2013; 208:184.e1.
[10] Winer R, Hughes JP, Feng Q, et al. Consistent condom use from time of first vaginal intercourse and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006: 354;2645-2654.
